Emmis Acquisition Corp Net Income per Employee (EMIS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Emmis Acquisition Corp   (NASDAQ: EMIS)
 

Emmis Acquisition Net Income per Employee

EMIS's Quarterly Results, Trends, Rankings, Statistics
Emmis Acquisition 's Income per employee grew in the first quarter 2026 on a trailing twelve month basis to $ 906,896, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 25 other companies achieving higher income per employee. While Emmis Acquisition 's total ranking has deteriorated compared to the previous quarter from to 218.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EMIS Net Income per Employee (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2017)
I. Quarter
Y / Y Net Income Change -83.95 % -79.29 % - - -
Net Income per Employee (TTM) $ 906,896 3,452,279 5,237,826 2,671,110 -1,074,000
EMIS's Total Ranking # 218 # # 42 # 78 #
Seq. Net Income Change 4.32 % - - - 34.64 %

EMIS Company Profile >> Back to EMIS Efficiency Comparisons >> Compare EMIS Net Income per Employee to its Competitors

EMIS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 26
Healthcare Sector # 33
Overall Market # 218

Net Income per Employee Statistics
High Average Low
$ 5,237,826 $ -9,056,347 $ -27,495,000
(Sep 30 2025)   (Mar 31 2015)







Companies with similar Income per Employee for 12 month ending Mar 31 2026, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2026Number of Employees Mar 31 2026
Xoma Royalty Corporation  1,423,714.29 $ 19.932  Million 14 
Q32 Bio Inc   1,385,125.00 $ 33.243  Million 24 
Petros Pharmaceuticals inc   1,289,601.00 $ 3.869  Million 3 
Theravance Biopharma inc   1,272,677.78 $ 114.541  Million 90 
Coherus Oncology inc   1,267,115.65 $ 186.266  Million 147 
Rafael Holdings Inc  1,224,608.70 $ 28.166  Million 23 
Catalyst Pharmaceuticals Inc   1,216,060.44 $ 221.323  Million 182 
Tg Therapeutics Inc   1,157,634.09 $ 461.896  Million 399 
Glucotrack Inc   1,125,933.33 $ 16.889  Million 15 
Ironwood Pharmaceuticals inc   1,021,760.00 $ 102.176  Million 100 
Silexion Therapeutics Corp  922,142.86 $ 12.910  Million 14 
United Therapeutics Corporation  919,571.43 $ 1,287.400  Million 1,400 
Emmis Acquisition Corp   906,895.50 $ 1.814  Million 2 
Halozyme Therapeutics Inc   824,687.94 $ 348.843  Million 423 
Prestige Consumer Healthcare Inc   785,608.77 $ 447.797  Million 570 
Agenus Inc  771,518.52 $ 62.493  Million 81 
Krystal Biotech Inc   762,813.56 $ 225.030  Million 295 
Elite Pharmaceuticals Inc   690,349.02 $ 44.873  Million 65 
Illumina Inc   666,406.25 $ 853.000  Million 1,280 
Engene Therapeutics Inc   623,048.78 $ 51.090  Million 82 
Spero Therapeutics Inc   609,400.00 $ 15.235  Million 25 
Amgen Inc   600,000.00 $ 7,800.000  Million 13,000 
Vaxart Inc   570,723.08 $ 37.097  Million 65 
Traws Pharma inc   567,529.41 $ 9.648  Million 17 
Entera Bio Ltd   562,590.91 $ 12.377  Million 22 
Gilead Sciences Inc   542,117.65 $ 9,216.000  Million 17,000 
Soleno Therapeutics Inc  527,692.31 $ 96.040  Million 182 
Sanuwave Health Inc   508,163.64 $ 27.949  Million 55 
Eli Lilly And Company  505,534.00 $ 25,276.700  Million 50,000 
Incyte Corporation  503,437.76 $ 1,431.777  Million 2,844 


Date modified: 2026-06-22T16:30:43+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.